Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma

BACKGROUND: G protein subunit gamma 12 (GNG12) is observed in some types of cancer, but its role in osteosarcoma is unknown. This study hypothesized that GNG12 may be a potential biomarker and therapeutic target. We aimed to identify an association between GNG12 and osteosarcoma based on the Gene Ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jinghong, Yuan, Zhao, Ye, Aifang, Wu, Tianlong, Jia, Jingyu, Guo, Jia, Zhang, Jian, Li, Tao, Cheng, Xigao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527884/
https://www.ncbi.nlm.nih.gov/pubmed/34691083
http://dx.doi.org/10.3389/fimmu.2021.758845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527884/
https://www.ncbi.nlm.nih.gov/pubmed/34691083
http://dx.doi.org/10.3389/fimmu.2021.758845

Ejemplares similares